Beyond the Brochure: Mastering the CDMO Partnership for Successful Tech Transfer with Klaus Dörre

How do you choose the right CDMO beyond a slick brochure? And once you do, how do you bridge the critical gap between brilliant R&D and the disciplined realities of GMP manufacturing?

In this episode, we're joined by Klaus Dörre, a seasoned professional with deep experience across cell and gene therapy and biologics. Having worked on both the innovator and the CDMO side, Klaus offers a rare 360-degree view of the tech transfer process.

We dive into the essential, yet often overlooked, elements of a successful partnership, including the mindset shift required to move from the lab to the plant.

In this episode, you will learn:

• The green flags to look for when selecting a manufacturing partner.

• Why robust analytics and well-defined potency assays are non-negotiable, even in early phases.

• The crucial difference between documenting research experiments and writing GMP-ready protocols and SOPs.

• How to build a relationship based on trust and transparency, turning your CDMO from a simple vendor into a true strategic partner.

• Key advice for early-stage companies on de-risking their CMC strategy to avoid costly delays.

  
  

This conversation is a must-listen for founders, CMC leaders, and scientists on the journey from discovery to clinical production. If you are approaching your first tech transfer, see how we can help.